Genomics

Dataset Information

0

Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (scRNA-Seq)

ABSTRACT: Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (scRNA-Seq)

PROVIDER: PRJNA1108777 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR28957762_1.fastq.gz Fastqsanger.gz
SRR28957762_2.fastq.gz Fastqsanger.gz
SRR28957763_1.fastq.gz Fastqsanger.gz
SRR28957763_2.fastq.gz Fastqsanger.gz
SRR28957764_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 16

Similar Datasets

Genomics Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (CUT&RUN)
2024-10-22 | GSE266949 | GEO
Transcriptomics Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (scRNA-Seq)
2024-10-22 | GSE266955 | GEO
Genomics Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (CUT&RUN) II
2024-10-22 | GSE272471 | GEO
Transcriptomics Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (RNA-Seq LNCaP)
2024-10-22 | GSE266950 | GEO
Transcriptomics Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (RNA-Seq organoids)
2024-10-22 | GSE266951 | GEO
Transcriptomics Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (RNA-Seq polysome)
2024-10-22 | GSE266954 | GEO
Genomics Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer
| PRJNA1108768 | ENA
Genomics Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (CUT&RUN)
| PRJNA1108766 | ENA
Genomics Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (RNA-Seq LNCaP)
| PRJNA1108767 | ENA
Genomics Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer (CUT&RUN) II
| PRJNA1136931 | ENA